Trials / Active Not Recruiting
Active Not RecruitingNCT07385053
Real-Life Evaluation of the HA Dermal Filler ESTYME® LIFT
Post-Marketing Clinical Follow Up of ESTYME® LIFT in the Correction of Nasolabial Folds
- Status
- Active Not Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 96 (actual)
- Sponsor
- Symatese · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
The objective of this post-market interventional study is to confirm, under real-life conditions, the safety and performance of a hyaluronic acid-based dermal filler intended for the aesthetic correction of nasolabial folds. The primary question addressed by the study is: How long does the effect of the product last? Following the initial injection session, which includes an optional touch-up planned one month after the first injection, participants will attend a follow-up visit scheduled between 9 and 24 months after the initial treatment. During this visit, patients may receive a retreatment if they wish. The flexibility of the follow-up window between 9 and 24 months was defined to allow patients to return on their own initiative for retreatment, thereby indicating the end of the effect of the initial injection session. A final follow-up visit is also scheduled at 24 months. At each visit, the investigator will assess both performance and safety through a clinical examination. In addition, at each follow-up visit, participants will evaluate the aesthetic improvement compared with their pre-injection appearance.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Injection of the Hyaluronic Acid-Based Dermal Filler ESTYME® LIFT (Now Marketed as ESTYME® FORM). | The device will be used under real-life conditions. Following the initial injection session, an optional touch-up may be performed one month after the first injection. A retreatment session may be offered to the patient between 9 and 24 months after the initial injection. |
Timeline
- Start date
- 2023-06-05
- Primary completion
- 2026-04-01
- Completion
- 2026-04-01
- First posted
- 2026-02-03
- Last updated
- 2026-02-03
Locations
3 sites across 1 country: France
Source: ClinicalTrials.gov record NCT07385053. Inclusion in this directory is not an endorsement.